VCM
CGON icon

Versant Capital Management’s CG Oncology CGON Stock Holding History

Versant Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77K Hold
39
– – ﹤0.01% 2521
2026
Q1 		$2.64K Hold
39
– – ﹤0.01% 2518
2025
Q4 		$1.62K Hold
39
– – ﹤0.01% 2469
2025
Q3 		$1.57K Hold
39
– – ﹤0.01% 2447
2025
Q2 		$1.01K Buy
39
+26
+200% +$627 ﹤0.01% 2485
2025
Q1 		$318 Sell
13
-400
-97% -$11.3K ﹤0.01% 2441
2024
Q4 		$11.8K Buy
+413
New +$14.1K ﹤0.01% 1313

Other funds holding CGON

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
EC
Eleva Capital Paris, France $343M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return